Recent News

• 02.13.2025 - Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements
• 02.10.2025 - Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy
• 02.07.2025 - Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch
• 02.07.2025 - Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch
• 02.06.2025 - Intelligent Bio Solutions Expects to Achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales
• 02.06.2025 - Intelligent Bio Solutions Expects to Achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales
• 02.06.2025 - Intelligent Bio Solutions Expects to Achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales
• 01.31.2025 - Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade
• 01.31.2025 - Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade
• 01.31.2025 - Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade

Recent Filings

• 02.10.2025 - 8-K Current report
• 02.10.2025 - EX-99.1 EX-99.1
• 02.07.2025 - EX-99.1 EX-99.1
• 02.07.2025 - 8-K Current report
• 02.06.2025 - 8-K Current report
• 02.06.2025 - EX-99.1 EX-99.1
• 02.04.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.31.2025 - 8-K Current report
• 01.31.2025 - EX-99.1 EX-99.1